Spiralin® is the result of a comprehensive biotech screening and a patented potentiation and standardization process. The speaker presents the unique activity profile of the ''active ingredient of the year 2015 in aesthetic dermatology''. Furthermore selected special care products with this ingredient are presented with experimental and clinical trial data and case studies.
Return to Speaker page
Tweet about it
Jörg Keimes
General Manager - Ocean Pharma GmbH
Patented microalgae active ingredient Spiralin® - USPs in special care products
About Jörg Keimes
Jörg Keimes is health care expert with 32 years of experience in national and international management positions in the pharma, diagnostic and cosmetic market. Since 2005 he is General Manager of ocean pharma (Reinbek/Germany) and additionally since 2020 Export Director of Cesra Arzneimittel (Baden Baden/Germany).